Article
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
Journal of the American College of Cardiology - 7 Jun 2016
Khera Amit V, Won Hong-Hee, Peloso Gina M, Lawson Kim S, Bartz Traci M, Deng Xuan, van Leeuwen Elisabeth M, Natarajan Pradeep, Emdin Connor A, Bick Alexander G, Morrison Alanna C, Brody Jennifer A, Gupta Namrata, Nomura Akihiro, Kessler Thorsten, Duga Stefano, Bis Joshua C, van Duijn Cornelia M, Cupples L Adrienne, Psaty Bruce, Rader Daniel J, Danesh John, Schunkert Heribert, McPherson Ruth, Farrall Martin, Watkins Hugh, Lander Eric, Wilson James G, Correa Adolfo, Boerwinkle Eric, Merlini Piera Angelica, Ardissino Diego, Saleheen Danish, Gabriel Stacey, Kathiresan Sekar
Abstract excerpt
BACKGROUND: Approximately 7% of American adults have severe hypercholesterolemia (untreated low-density lipoprotein [LDL] cholesterol ≥190 mg/dl), which may be due to familial hypercholesterolemia (FH). Lifelong LDL cholesterol elevations in FH mutation carriers may confer coronary artery disease (CAD) risk beyond that captured by a single LDL cholesterol measurement. OBJECTIVES: This study assessed the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
